全文获取类型
收费全文 | 1542759篇 |
免费 | 115583篇 |
国内免费 | 17997篇 |
专业分类
耳鼻咽喉 | 21518篇 |
儿科学 | 42296篇 |
妇产科学 | 41383篇 |
基础医学 | 211958篇 |
口腔科学 | 43205篇 |
临床医学 | 142467篇 |
内科学 | 293165篇 |
皮肤病学 | 32193篇 |
神经病学 | 117933篇 |
特种医学 | 61485篇 |
外国民族医学 | 573篇 |
外科学 | 228509篇 |
综合类 | 65675篇 |
现状与发展 | 61篇 |
一般理论 | 454篇 |
预防医学 | 104672篇 |
眼科学 | 37768篇 |
药学 | 121871篇 |
198篇 | |
中国医学 | 15221篇 |
肿瘤学 | 93734篇 |
出版年
2021年 | 18586篇 |
2020年 | 13465篇 |
2019年 | 15313篇 |
2018年 | 19476篇 |
2017年 | 16426篇 |
2016年 | 16976篇 |
2015年 | 21833篇 |
2014年 | 28838篇 |
2013年 | 35530篇 |
2012年 | 48416篇 |
2011年 | 52191篇 |
2010年 | 30907篇 |
2009年 | 28110篇 |
2008年 | 44207篇 |
2007年 | 47245篇 |
2006年 | 48009篇 |
2005年 | 46921篇 |
2004年 | 41713篇 |
2003年 | 40351篇 |
2002年 | 38818篇 |
2001年 | 67661篇 |
2000年 | 69867篇 |
1999年 | 60454篇 |
1998年 | 17961篇 |
1997年 | 16798篇 |
1996年 | 15651篇 |
1995年 | 14745篇 |
1994年 | 13543篇 |
1992年 | 44390篇 |
1991年 | 42656篇 |
1990年 | 41631篇 |
1989年 | 40437篇 |
1988年 | 37784篇 |
1987年 | 37095篇 |
1986年 | 35478篇 |
1985年 | 33533篇 |
1984年 | 25080篇 |
1983年 | 21233篇 |
1979年 | 24024篇 |
1978年 | 17103篇 |
1977年 | 14872篇 |
1976年 | 13401篇 |
1975年 | 15300篇 |
1974年 | 18121篇 |
1973年 | 17586篇 |
1972年 | 16845篇 |
1971年 | 15740篇 |
1970年 | 14931篇 |
1969年 | 14364篇 |
1968年 | 13473篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
161.
Mayuko Kinoshita Haruka Kaneko Lizu Liu Masashi Nagao Ryo Sadatsuki 《Modern rheumatology / the Japan Rheumatism Association》2019,29(1):157-164
Objectives: To examine the factors associated with increase in lumbar spine bone mineral density (LS-BMD) by bisphosphonates (BPs) with active vitamin D analog (aVD).Methods: Two independent postmenopausal osteoporotic patients treated by BPs with aVD for 24 months (Study 1: n?=?93, Study 2: n?=?99) were retrospectively analyzed.Results: In Study 1, LS-BMD of the patients significantly increased for 24 m (5.4%, p?.001). A multiple regression analysis among baseline characteristics revealed that serum calcium (sCa: 8.5–10.5?mg/dL) was associated with an increased LS-BMD by treatment (r2: 0.088, p?=?.02). While average sCa of the patients was 9.2?mg/dL before treatment, it increased time-dependently to 9.6?mg/dL for 24 m by treatment. As each patient had their LS-BMD five times during the study, there were four instances of %LS-BMD in each patient, resulting in 372 instances of %LS-BMD in Study 1. The smallest Akaike’s information criterion value for the most appropriate cut-off levels of sCa for %LS-BMD by treatment every 6 m was 9.3?mg/dL. The %LS-BMD by treatment for 6 m during 24 m period in patients with sCa ≥9.3?mg/dL (1.5%) was significantly higher than that in patients with sCa <9.3?mg/dL (0.8%, p?=?.038). The results of Study 2 were similar to those of Study 1, confirming the phenomena observed.Conclusion: sCa was associated with an increased LS-BMD by BPs with aVD. 相似文献
162.
Denise Lee Marcella D. Walker Hsin Yi Chen John A. Chabot James A. Lee Jennifer H. Kuo 《Surgery》2019,165(1):107-113
Background
Bone mineral density (BMD) has been found to improve after parathyroidectomy (PTX) in patients with primary hyperparathyroidism. There are few data on the effect of PTX on BMD in normocalcemic and normohormonal primary hyperparathyroidism.Methods
A retrospective analysis of 92 primary hyperparathyroidism patients who underwent PTX between 2004 and 2012 with pre- and post-PTX dual-energy x-ray absorptiometry was performed. Within-person changes in BMD pre- and post-PTX were analyzed using log linear mixed models, stratified by biochemical status.Results
Bone mineral density increased post-PTX in the whole cohort at the lumbar spine (+2.5%), femoral neck (+2.1%), and total hip (+1.9%) and decreased at the one-third radius (–0.9%). On comparison of BMD changes by profile, BMD increased in those with the typical profile at the lumbar spine (3.2%), femoral neck (2.9%), and total hip (2.9%) but declined at the one-third radius (–1.5%). In contrast, BMD improved only at the femoral neck (4.3%) in the normohormonal group and did not change at any site in the normocalcemic group. The typical group had a greater increase in BMD over time at the femoral neck and total hip compared with normocalcemic patients.Conclusion
Our results indicate that the skeletal benefit of PTX was attenuated in normocalcemic and normohormonal patients, suggesting that skeletal changes after PTX may depend on biochemical profile. 相似文献163.
164.
165.
166.
Chien-Hua Tseng Ben-Jei Tsuang Chun-Ju Chiang Kai-Chen Ku Jeng-Sen Tseng Tsung-Ying Yang Kuo-Hsuan Hsu Kun-Chieh Chen Sung-Liang Yu Wen-Chung Lee Tsang-Wu Liu Chang-Chuan Chan Gee-Chen Chang 《Journal of thoracic oncology》2019,14(5):784-792
Introduction
For never-smokers (smoked <100 lifetime cigarettes), lung cancer (LC) has emerged as an important issue. We aimed to investigate the effects of prevalence changes in tobacco smoking and particulate matter (PM) 2.5 (PM2.5) levels on LC in Taiwan, in relation to contrasting PM2.5 levels, between Northern Taiwan (NT) and Southern Taiwan (ST).Methods
We reviewed 371,084 patients with LC to assess smoking prevalence and correlations between the incidence of adenocarcinoma lung cancer (AdLC) and non-AdLC. Two subsets were selected to assess different AdLC stage trends and the effect of PM2.5 on survival of patients with AdLC.Results
From 1995 to 2015, the proportion of male adult ever-smokers decreased from 59.4% to 29.9% whereas the female smoking rate remained low (3.2% to 5.3%). AdLC incidence in males and females increased from 9.06 to 23.25 and 7.05 to 24.22 per 100,000 population, respectively. Since 1993, atmospheric visibility in NT improved (from 7.6 to 11.5 km), but deteriorated in ST (from 16.3 to 4.2 km). The annual percent change in AdLC stages IB to IV was 0.3% since 2009 (95% confidence interval [CI]: -1.9%–2.6%) in NT, and 4.6% since 2007 (95% CI: 3.3%–5.8%) in ST; 53% patients with LC had never smoked. Five-year survival rates for never-smokers, those with EGFR wild-type genes, and female patients with AdLC were 12.6% in NT and 4.5% in ST (hazard ratio: 0.79, 95% CI: 0.70–0.90).Conclusions
In Taiwan, greater than 50% of patients with LC had never smoked. PM2.5 level changes can affect AdLC incidence and patient survival. 相似文献167.
168.
169.
170.
Yinong Young-Xu Julia Thornton Snider Robertus van Aalst Salaheddin M. Mahmud Edward W. Thommes Jason K.H. Lee David P. Greenberg Ayman Chit 《Vaccine》2019,37(11):1484-1490